ΠΠΎΠ»ΠΈΠ³Π΅Π½Π½ΡΠΉ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ ΡΠ΅Π°ΠΊΡΠΈΠΉ, ΠΎΠΏΡΠ΅Π΄Π΅Π»ΡΡΡΠΈΡ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΡ ΠΌΡΡΠ΅ΠΉ ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ
ΠΠΈΡΡΠ΅ΡΡΠ°ΡΠΈΡ
ΠΠ°ΠΏΡΠΈΠΌΠ΅Ρ, ΡΠ΅ Π²ΠΈΠ΄Ρ ΠΌΠΈΠΊΠΎΠ±Π°ΠΊΡΠ΅ΡΠΈΠΉ, ΠΊΠΎΡΠΎΡΡΠΌΠΈ ΠΎΠ±ΡΡΠ½ΠΎ ΠΈΠ½ΡΠΈΡΠΈΡΡΡΡ ΠΌΡΡΠ΅ΠΉ Π² ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Ρ (Π tuberculosis, Π. bovis BCG, Π. avium), Π½Π΅ ΡΠ²Π»ΡΡΡΡΡ ΠΏΡΠΈΡΠΎΠ΄Π½ΡΠΌΠΈ ΠΌΡΡΠΈΠ½ΡΠΌΠΈ ΠΏΠ°ΡΠΎΠ³Π΅Π½Π°ΠΌΠΈ, Π² ΠΎΡΠ»ΠΈΡΠΈΠ΅ ΠΎΡ Π. microti. Π ΡΠΎΠΌΡ ΠΆΠ΅, ΡΠ°ΡΡΠΎ ΠΈΡΠΏΠΎΠ»ΡΠ·ΡΠ΅ΠΌΡΠ΅ ΠΏΡΡΠΈ Π·Π°ΡΠ°ΠΆΠ΅Π½ΠΈΡ (ΡΠ°ΠΊΠΈΠ΅ ΠΊΠ°ΠΊ Π²Π½ΡΡΡΠΈΠ²Π΅Π½Π½ΠΎΠ΅, Π²Π½ΡΡΡΠΈΡΡΠ°Ρ Π΅Π°Π»ΡΠ½ΠΎΠ΅ Π²Π²Π΅Π΄Π΅Π½ΠΈΠ΅ Π±Π°ΠΊΡΠ΅ΡΠΈΠΉ ΠΌΡΡΠ°ΠΌ), Π·Π½Π°ΡΠΈΡΠ΅Π»ΡΠ½ΠΎ ΠΎΡΠ»ΠΈΡΠ°Π΅ΡΡΡ ΠΎΡ Π΅ΡΡΠ΅ΡΡΠ²Π΅Π½Π½ΠΎΠ³ΠΎ, Π²ΠΎΠ·Π΄ΡΡΠ½ΠΎ-ΠΊΠ°ΠΏΠ΅Π»ΡΠ½ΠΎΠ³ΠΎ ΠΏΡΡΠΈ ΠΈΠ½ΡΠΈΡΠΈΡΠΎΠ²Π°Π½ΠΈΡ. ΠΡΠΎΠΌΠ΅ ΡΠΎΠ³ΠΎ… Π§ΠΈΡΠ°ΡΡ Π΅ΡΡ >
Π‘ΠΏΠΈΡΠΎΠΊ Π»ΠΈΡΠ΅ΡΠ°ΡΡΡΡ
- Π© 1. ΠΠ²Π΅ΡΠ±Π°Ρ Π. Π. (ΡΠ΅Π΄.) (1976) ΠΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ ΠΈ ΠΈΠΌΠΌΡΠ½ΠΎΠΏΠ°ΡΠΎΠ»ΠΎΠ³ΠΈΡ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π°. Π.1. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°, Ρ. 312.
- ΠΠ²Π΅ΡΠ±Π°Ρ Π.Π., ΠΠΎΡΠΎΠ· A.M., ΠΠΏΡ Π.Π‘., ΠΠΈΠΊΠΎΠ½Π΅Π½ΠΊΠΎ Π. Π. (1985) ΠΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π΅ΡΠΈΠΊΠ° ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΎΠ½Π½ΡΡ Π·Π°Π±ΠΎΠ»Π΅Π²Π°Π½ΠΈΠΉ. Π. ΠΠ΅Π΄ΠΈΡΠΈΠ½Π°, Ρ. 256.
- ΠΠ²Π΅ΡΠ±Π°Ρ Π.Π., ΠΠΎΡΠΎΠ· A.M., ΠΠΏΡ Π.Π‘., Π’ΠΎΡΠΎΠ½Π΄ΠΆΠ°Π΄Π·Π΅ Π., ΠΠ»ΡΠΈΠ½Π° Π. Π. (1980) ΠΠ΅ΠΆΠ»ΠΈΠ½Π΅ΠΉΠ½ΡΠ΅ ΡΠ°Π·Π»ΠΈΡΠΈΡ ΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ ΠΌΡΡΠ΅ΠΉ ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ. ΠΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡ, 2, 42−43.
- ΠΠΏΡ Π.Π‘. (2001) ΠΠ΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ Π²ΡΡΠ²Π»Π΅Π½ΠΈΡ Π³ΡΡΠΏΠΏ ΡΠΈΡΠΊΠ° ΠΏΠΎ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ. ΠΡΠΎΠ±Π»Π΅ΠΌΡ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π°. 7, 65−68.
- ΠΠΏΡ Π. Π‘. Π Π΅Π³ΡΠ»ΡΡΠΈΡ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° ΠΊ Π²Π½ΡΡΡΠΈΠΊΠ»Π΅ΡΠΎΡΠ½ΡΠΌ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΡΠΌ Π³Π΅Π½Π°ΠΌΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° Π-2 (Π½Π° ΠΏΡΠΈΠΌΠ΅ΡΠ΅ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π°). ΠΠΈΡΡ. Π΄ΠΎΠΊΡΠΎΡΠ° Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π½Π°ΡΠΊ. Π., 1991.
- ΠΠΏΡ Π.Π‘., ΠΠΈΠΊΠΎΠ½Π΅Π½ΠΊΠΎ Π. Π., ΠΠΎΡΠΎΠ· A.M., ΠΠ²Π΅ΡΠ±Π°Ρ Π. Π. (1982) ΠΠ΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· ΡΠ°ΠΊΡΠΎΡΠΎΠ², Π΄Π΅ΡΠ΅ΡΠΌΠΈΠ½ΠΈΡΡΡΡΠΈΡ Π²ΠΎΡΠΏΡΠΈΠΈΠΌΡΠΈΠ²ΠΎΡΡΡ ΠΌΡΡΠ΅ΠΉ ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ. ΠΡΠ»Π». ΠΠΊΡΠΏ. ΠΠΈΠΎΠ». ΠΠ΅Π΄. 12, 83−85.
- ΠΠΏΡ Π.Π‘., ΠΠΈΠΊΠΎΠ½Π΅Π½ΠΊΠΎ Π. Π., ΠΠΎΡΠΎΠ· A.M., ΠΠ²Π΅ΡΠ±Π°Ρ Π. Π. (1988) Π Π΅Π³ΡΠ»ΡΡΠΈΡ ΠΏΡΠΎΡΠΈΠ²ΠΎΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° Π³Π΅Π½Π°ΠΌΠΈ ΠΊΠΎΠΌΠΏΠ»Π΅ΠΊΡΠ° Π-2. ΠΡΠ»Π». ΠΠΊΡΠΏ. ΠΠΈΠΎΠ». ΠΠ΅Π΄. 106, 73−75.
- ΠΠ»Π°Π½Π΄ΠΎΠ²Π° Π.Π., ΠΠ°Π»Π°ΡΠ΅Π½ΠΊΠΎ A.M., ΠΡΡΡΠΊΠΈΠ½ΠΎΠΉ Π. Π., Π‘Π΅ΠΌΠ΅Π½ΠΎΠ² Π₯.Π₯, Π¨ΠΌΠΈΠ΄Ρ Π. Π€. (1979) ΠΡΠ°Π²ΠΈΠ»Π° ΡΠ°Π·Π²Π΅Π΄Π΅Π½ΠΈΡ ΠΈΠ½Π±ΡΠ΅Π΄Π½ΡΡ Π»Π°Π±ΠΎΡΠ°ΡΠΎΡΠ½ΡΡ ΠΆΠΈΠ²ΠΎΡΠ½ΡΡ . Π‘Π±ΠΎΡΠ½ΠΈΠΊ ΠΠΊΠ°Π΄Π΅ΠΌΠΈΠΈ ΠΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ ΠΠ°ΡΠΊ Π‘Π‘Π‘Π .
- ΠΡΡΡΠ»Π°Π½ΠΎΠ² Π.Π. ΠΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½Π°Ρ ΠΌΠΎΠ΄Π΅Π»Ρ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π° ΠΏΡΠΈ Π²Π½ΡΡΡΠΈΡΡΠ°Ρ Π΅Π°Π»ΡΠ½ΠΎΠΌ Π·Π°ΡΠ°ΠΆΠ΅Π½ΠΈΠΈ: ΠΈΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ. ΠΠΈΡΡ. ΠΊΠ°Π½Π΄ΠΈΠ΄Π°ΡΠ° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ Π½Π°ΡΠΊ. Π., 2002.
- ΠΠ°ΠΉΠΎΡΠΎΠ² Π.Π. ΠΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠ΅ Π°ΡΠΏΠ΅ΠΊΡΡ ΡΡΠ½ΠΊΡΠΈΠΎΠ½Π°Π»ΡΠ½ΠΎΠΉ Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΠΈ ΠΌΠ°ΠΊΡΠΎΡΠ°Π³ΠΎΠ² ΠΏΡΠΈ ΡΠΊΡΠΏΠ΅ΡΠΈΠΌΠ΅Π½ΡΠ°Π»ΡΠ½ΠΎΠΌ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π΅. ΠΠΈΡΡ. ΠΊΠ°Π½Π΄ΠΈΠ΄Π°ΡΠ° Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π½Π°ΡΠΊ. Π., 2001.
- Π.ΠΠ΅ΠΆΠ»ΡΠΌΠΎΠ²Π° Π. Π. (1990) ΠΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΠΉ Π°Π½Π°Π»ΠΈΠ· Π³ΠΈΠΏΠ΅ΡΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π·Π°ΠΌΠ΅Π΄Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΈΠΏΠ° ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»ΠΈΠ½Ρ Ρ ΠΌΡΡΠ΅ΠΉ ΠΌΠ΅ΡΠΎΠ΄ΠΎΠΌ Π»ΠΎΠΊΠ°Π»ΡΠ½ΠΎΠ³ΠΎ Π°Π΄ΠΎΠΏΡΠΈΠ²Π½ΠΎΠ³ΠΎ ΠΏΠ΅ΡΠ΅Π½ΠΎΡΠ°. ΠΡΠΎΠ±Π»Π΅ΠΌΡ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π° 4, 55−58.
- ΠΠΎΡΠΎΠ· A.M. ΠΠΌΠΌΡΠ½ΠΎΠ³Π΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈΠΉ ΠΌΠ΅Ρ Π°Π½ΠΈΠ·ΠΌ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Ρ. (1984) ΠΠΈΡΡ. Π΄ΠΎΠΊΡΠΎΡΠ° Π±ΠΈΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠΈΡ Π½Π°ΡΠΊ. Π., 214Ρ.
- ΠΠΎΡΠΎΠ· A.M., Π’ΠΎΡΠΎΠ½Π΄ΠΆΠ°Π΄Π·Π΅ Π. Π. (1977) ΠΠ΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠΈ ΠΎΠ±ΡΡΠ»ΠΎΠ²Π»Π΅Π½Π½Π°Ρ ΠΈΠΌΠΌΡΠ½ΠΎΠ»ΠΎΠ³ΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ΅Π°ΠΊΡΠΈΠ²Π½ΠΎΡΡΡ ΠΌΡΡΠ΅ΠΉ ΡΠ°Π·Π»ΠΈΡΠ½ΡΡ Π»ΠΈΠ½ΠΈΠΉ ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π½ΠΎΠΉ ΠΈΠ½ΡΠ΅ΠΊΡΠΈΠΈ. Π‘Π±. ΡΡΡΠ΄ΠΎΠ² Π¦ΠΠΠ ΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π°, Π’.21, Ρ. 131−133.
- ΠΠΈΠΊΠΎΠ½Π΅Π½ΠΊΠΎ Π.Π. ΠΠΎΠ»ΠΈΠ³Π΅Π½Π½ΡΠΉ ΠΊΠΎΠ½ΡΡΠΎΠ»Ρ ΠΏΡΠΎΡΠΈΠ²ΠΎΡΡΠ±Π΅ΡΠΊΡΠ»Π΅Π·Π½ΠΎΠ³ΠΎ ΠΈΠΌΠΌΡΠ½ΠΈΡΠ΅ΡΠ° ΠΈ ΡΠ΅Π·ΠΈΡΡΠ΅Π½ΡΠ½ΠΎΡΡΠΈ. ΠΠΈΡΡ. Π΄ΠΎΠΊΡΠΎΡΠ° ΠΌΠ΅Π΄ΠΈΡΠΈΠ½ΡΠΊΠΈΡ Π½Π°ΡΠΊ. Π., 1992.
- ΠΠΈΠΊΠΎΠ½Π΅Π½ΠΊΠΎ Π.Π., ΠΠ΅ΠΆΠ»ΡΠΌΠΎΠ²Π° Π. Π., ΠΠΏΡ Π.Π‘., ΠΠΎΡΠΎΠ· A.M. (1988) ΠΠ΅Π½Π΅ΡΠΈΡΠ΅ΡΠΊΠ°Ρ ΡΠ΅ΡΡΡΠΈΠΊΡΠΈΡ Π³ΠΈΠΏΠ΅ΡΡΡΠ²ΡΡΠ²ΠΈΡΠ΅Π»ΡΠ½ΠΎΡΡΠΈ Π·Π°ΠΌΠ΅Π΄Π»Π΅Π½Π½ΠΎΠ³ΠΎ ΡΠΈΠΏΠ° ΠΊ ΡΡΠ±Π΅ΡΠΊΡΠ»ΠΈΠ½Ρ Ρ ΠΌΡΡΠ΅ΠΉ. ΠΠ΅Π½Π΅ΡΠΈΠΊΠ° 9, 1707−1709.
- ΠΠΈΠΊΠΎΠ½Π΅Π½ΠΊΠΎ Π.Π., ΠΠΏΡ Π.Π‘., ΠΠ΅ΠΆΠ»ΡΠΌΠΎΠ²Π° Π. Π., ΠΠΎΡΠΎΠ· A.M. (1990) ΠΠ΅Π½Ρ Beg ΠΈ Π’Π¬Ρ-1, Π²Π·Π°ΠΈΠΌΠΎΡΠ²ΡΠ·Ρ. ΠΠ΅Π½Π΅ΡΠΈΠΊΠ° 26, 2254−2257.
- Abel L, Sanchez F.O., Oberti J, Thuc N. V, Hoa L. V, Lap V. D, Skamene E, Lagrange P. H, Schurr E (1998) Susceptibility to leprosy is linked to the human NRAMP1 gene. J Infect Dis. 177,133−145.
- Altare F., Durandy A., Lammas D., et al. (1998) Impairment of Mycobacterial immunity on human IL-12 receptor deficiency. Science 280,1432−1435.
- Apt A., Avdienko V., Nikonenko B. et al. (1993) Distinct H-2 complex control of mortality, and immune responses to tuberculosis infection in virgin and BCG-vaccinated mice. Clin. Exp. Immunol. 94, 322−329.
- Arias M., Rojas M., Zabelta J., Rodriguez C., Paris S., Barrera L.F. and Garcia L.F. (1997) Inhibition of virulent M. tuberculosis by Bcgr and Bcgs macrophages correlates with nitric oxide production. J. Infect. Dis. 176, 1552−1560.
- Awomoyi A., Marchant A., Howson J., McAdam K., Blackwell J. and Newport M. (2002) Interleukin-10, polymorphism in SLC11A1 (formerly NRAMP1) and susceptibility to tuberculosis. J. Infect. Dis. 186, 1808−1814.
- Baltimore D. (2001) Our genome unveiled. Nature 409, 814−816.
- Bartz H., Buning-Pfaue F., turkel O., Schauer U. (2002) Respiratory syncytial virus induced prostaglandin E2, IL-10 and IL-11 generation in antigen presenting cells. Clin. Exp. Immunol. 129, 438−445.
- Behr M., Wilson M., Gill W.P., Salamon H., Schoolnik G.K., Rane S., Small P.M. (1999) Comparative genomics of BCG vaccines by whole-genome DNA microarray. Science 284, 1520−1523.
- Bellamy R. and Hill A.V. (1998) Genetic susceptibility to mycobacteria and other infectious pathogens in humans. Curr. Opin. Immunol. 10,483−487.
- Bellamy R., Beyers N., McAdam K., Ruwende C. et al. (2000) Genetic susceptibility to tuberculosis in Africans: A genome-wide scan. PNAS USA, 97, 8005−8009.
- Bellamy R.J. (1998) Genetic susceptibility to tuberculosis in human populations. Thorax 53, 588−593.
- Benedek-Spat E., Di Felice R., Andersen E., Cimasoni G. (1991) In vitro release of elastase from human blood and gingival circular neutriphils. Arch. Oral. Biol. 36, 507 510.
- Bloom B.R. (1994) Tuberculosis: Pathogenesis, Protection, and Control. Washington, DC: ASM Press, pp. 637
- Boehm T. (1998) Positional cloning and gene identification. Methods 14, 152−158.
- Boldrick JC, Alizadeh AA, Diehn M, Dudoit S, Liu CL, Belcher CE, Botstein D, Staudt LM, Brown PO, Relman DA. (2002) Stereotyped and specific gene-expression programs in human innate immune responses to bacteria. PNA S USA 99, 972−977.
- Bonner A.E., Lemon W.J., You M. (2003) Gene expression signatures identify novel regulatory pathways during murine lung development: implication for lung tumorigenesis. J. Med. Genet. 40,408−417.
- Boom W.H., Husson R.N., Young A., David J.R., Piessens W.F. (1987) In vivo and in vitro characterization of murine T-cell clones reactive to Mycobacterium tuberculosis. Infect. Immun. 55,2223−2229.
- Boyartchuk V. And Dietrich W. (2002) Genetic dissection of host immune response. Genes and Immunity 3,119−122.
- Bradley D.J., Taylor Π.A., Blackwell J.M., Evans E.P., Freem J. (1979) Regulation of Leishmania population within the host. III. Mapping of the locus controlling susceptibility to visceral leishmaniasis in the mouse. Clin Exp Immunol 30, 130−140.
- Brett S.J., Ivanyi J. (1990) Genetic influences on the immune repertoire following tuberculosis infection in mice. Immunology 71, 113−119.
- Brett S.J., Orrell J.M., Swanson-Beck J., Ivanyi J. (1992) Influence of H-2 genes on growth of Mycobacterium tuberculosis in the lungs of chronically infected mice. Immunology 76,129−132.
- Buschman E., Apt A.S., Nikonenko B.V., Moroz A.M., Averbakh M.M. and Skamene E (1988). Genetic aspects of innate resistance and acquired immunity to mycobacteria in inbred mice. Springer Semin. Immunopathol. 10, 319−336.
- Casanova J.-L. and Abel L. (2002) Genetic Dissection of Immunity to Mycobacteria: The Human Model. Annu. Rev. Immunol. 20, 581−630.
- Casanova J.-L. and Abel L. (2004) The human model: a genetic dissection of immunity to infection in natural conditions. Nature Rev. Immunol. 4, 55−66.
- Cellier M., Belouchi A. and Gros P. (1996) Resistance to intracellular infections: comparative genome of NRAMP. Trends Genet. 12, 202−204.
- Cellier M., Prive G., Belouchi A., Kwan Π’., Rodriguezs V., Chia W. and Gros P. (1995) The natural resistance associated macrophage protein (Nramp) defines a new family of membrane proteins conserved throughout evolution. PNAS USA 92,10 089−10 094.
- Cervino A.C.L., Lakiss S., Sow O. and Hill A.V.S. (2000) Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry. Ann. Hum. Genet 64,507−512.
- Chan F.K., Siegel R.M., Lenardo M.J. (2000) Signaling by the TNF receptor superfamily and T cell homeostasis. Immunity 13, 419−422.
- Chan J., Xing Y., Magliozzo R.S., Bloom B. (1992) Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175,1111−1122.
- Chan, J., Tanaka K., Carroll D., Flynn J., Bloom B. (1995) Effects of nitric oxide synthase inhibitors on murine infections with Mycobacterium tuberculosis. Infect. Immun. 63, 736−740.
- Chang J.C., Wysocki A., Tchou-Wong K.M., Moskowitz N., Zhang Y., Rom W.N. (1996) Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 51,306−311.
- Cohen P., Bouaboula M., Bellis M., Baron V., Jbilo O., Poinot-Chazel C., Galiegue S., Hadibi E., Casellas P. (2000) Monitoring cellular responses to Listeria monocytogenes with oligonucleotide arrays. J. Biol. Chem. 275,11 181−11 190.
- Comstock G.W. (1978) Tuberculosis in twins: a re-analysis of the Prophit survey. Am. Rev. Respir. 117,621−624.
- Cooper A.M., D’Souza C., Frank A.A., Orme I. M. (1997) The course of M. tuberculosis infection in the lungs of mice lacking expressions of either perforin- or granzyme-mediated cytolytic mechanisms. Infect. Immun. 65, 1317−1320.
- Crocker P.R., Blackwell J.M. and Bradley D.J. (1084) Expression of the natural resistance gene Lsh in resident liver macrophages. Infect. Immun. 43, 1033−1040.
- Dalton D.K., Pitts-Meek S., Keshav S., et al. (1993) Multiple defects of immune call function in mice with disrupted interferon-y genes. Science 259, 1739−1742.
- Darvasi A., Weinreb A., Minke V., Weller J.I. and Soller M. (1993) Detecting marker QTL linkage and estimating QTL gene effects and map location using a saturated genetic map. Genetics 134, 943−951.
- Das G., Vohra H., Saha Π., Agrewala J.N., Mishra G.C. (1999) Apoptosis of Thl-like cells in experimental tuberculosis (Π’Π). Clin. Exp. Immunol. 115, 324−328.
- Denis M., Forget A., Pelletier M., Gervais F. and Skamene E. (1990) Killing of Mycobacterium smegmatis by macrophages from genetically susceptible and resistant mice. J. Leukoc. Biol. 47,25−30.
- DeRisi J., Penland L., Brown P.O., Bittner M.L., Meltzer P. S., Ray M., Chen Y., Su Y.A., Trent J.M. (1996) Use of cDNA microarray to analyse gene expression patterns in human cancer. Nat. Genet. 14,457−460.
- DeRisi J.L., Iyer V.R. and Brown PO. (1997) Exploring the metabolic and genetic control of gene expression on a genomic scale. Science 278, 680−686.
- Dietrich W.F., Damron D.M., Isberg R.R., Lander E.S. Swanson M.S. (1995) Lgnl, a gene that determines susceptibility to Legionella pneimophila, maps to mouse chromosome 13. Genomis 26,443−450.
- Doffinger R., Dupuis S., Picard C., Fieschi C., Feinberg J., Bercevas-Morales G., and Casanova J.-L. (2001) Inherited dosprders of IL-12 and IFNy-mediated immunity: a molecular genetics update. Mol. Immunol. 38, 903−909.
- Dollery C.M., Owen C.A., Sukhova G.K., Krettek A., Shapiro S.D., Libby P. (2003) Neutrophil elastase in human atherosclerotic plaques: production by macrophages. Circulation 10,2829−2836.
- Doucet Π‘., Brouty-Boye D., Pottin-Clemenceau C., Jasmin C., Canonica G.W., Azzarone B. (1998) IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int. Immunol. 10, 14 211 433.
- Dubos R. and Dubos J. (1952) in The White Plaque: Tuberculosis, Man ans Society (Little, Brown, Boston), 1−207.
- Ehlers S., Kutsch S., Ehlers E.M., Benini J., and Pfeffer K. (2000) Lethal granuloma disintegration in mycobacteria-infected TNFRp55-/- mice is dependent on T cell and II-12. J. Immunol 165,483−492.
- Einarsson O., Geba P.G., Zhu Z., Landry m., Elias J.A. (1996) Interleukin 11: stimulation in vivo and in vitro by respiratory viruses and induction of airways hyperresponsiveness. J. Clin. Invest. 97, 915−924.
- Elias J.A., Zheng Π’., Whiting N.L., Trow Π’.Π., Merril W.W., Zitnik R., Ray P., Alderman E.M. (1994a) Interleukin-1 and transforming growth factor p regulation of fibroblast-derived interleukin-11. J. Immunol. 152, 2421−2429.
- Elias J.A., Zheng Π’., Einarsson O., Landry M., Trow Π’., Rebert N., Panuska J. (1994b) Epithelial interleukin-11. Regulation by cytokines, respiratory syncytial virus, and retinoic acid. J Biol Chem. 269, 22 261−22 268.
- Elias J.A., Wu Y., Zheng Π’., Panettieri R. (1997) Cytokine- and virus-stimulated airway smooth muscle cells produce IL-11 and other IL-6-type cytokines. Am J Physiol. 273, L648-L655.
- Eruslanov E.B., Lyadova I.V., Kondratieva Π’.Π., Orlova M.O., Apt A.S. (2004b) Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. In press.
- Eskra L., Mathison A. and Splitter G. (2003) Microarray analysis of mRNA levels from RAW264.7 macrophages infected with Brucella abortus. Infect. Immun. 71, 1125−1133.
- Fahrer AM, Bazan JF, Papathanasiou P, Nelms KA, Goodnow CC. (2001)A genomic view of immunology. Nature 409, 836−838.
- Felming M.D., Romano M.A., Su M.A., Garrick L.M., Garrick M.D. and Andrews N.C. (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. PNAS USA 95, 1148−1153.
- Fenton M.J., Vermuelen M.W., Kim S., Burdick M., Strieter R.M., Kornfeld H. (1997) Induction of gamma-interferon production in human alveolar macrophages by Mycobacterium tuberculosis. Infect. Immun. 65, 5149−5156.
- Finlay G.A., O’Driscoll L.R., Russel K.J., D’Arcy E.M., Masterson J.B., Fitzgerald M.X., O’Connor C.M. (1997) Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am. J. Respir. Crit. Care. Med. 156, 240−247.
- Fleming M.D., Trenor III C.C., Su M.A., Foernzler D., Beier D.R., Dietrich W.F. and Andrews N.C. (1997) Microcytic anemia mice have a mutation in Nramp2, a candidate iron transporter gene. Nat. Genet 16,338−386.
- Flynn J.L., Chan J., Triebold K.J., Dalton D.K., Stewart T.A., Bloom B.R. (1993) An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med 178,2249−2254.
- Flynn J.L., Chan J. (2001) Immunology of tuberculosis. Ann. Rev. Immunol. 19, 93 129.
- Fodor D.J., Read J.L., Pirrung M.C., Stryer L., Lu A.T., Solas D. (1991) Light-directed, spatially addressable parallel chemical synthesis. Science 251, 767−773.
- Forget A., Skamene E., Gros P., Miaihle A.-C., Turcotte R. (1981) Strain differences in the response to infection with small dispersed doses of Mycobacterium bovis BCG among inbred mice. Infect. Immun. 32, 42−47.
- Fortin A., Diez E., Rochefort D., Laroche L., Malo D., Rouleau G., Gros P. and Skamene E. (2001) Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. Genomics 74,21−35.
- Fortin A., Stevenson M.M. and Gros P. (2002) Complex genetic control of susceptibility to malaria in mice. Genes and Immunity 3,177−186.
- Fujie K., Shinguh Y., Inamura N., Yasumitsu R., Okamoto M., Okuhara M. (1999) Release of neutrophil elastase and its role in tissue injury in acute inflammation: effect of the elastase inhibitor, FR134043. Eur J Pharmacol. 374,117−125.
- Gao J.J., Diesl V., Wittmann Π’., Morrison D.C., Ryan J.L., Vogel S.N., Follettie M.T. (2002) Regulation of gene expression in mouse macrophages stimulated with bactericidal CpG-DNA and lipopolysaccharide. J. Leuk. Biol. 72,1234−1245.
- Gibbs D.F., Shanley T.P., Warner R.L., Murphy H.S., Varani J., Johnson K.J. (1998) Role of matrix metalloproteinase in model of macrophages-dependant acute lung injury. Am. J. Respir. Cell Mol. Biol. 20,1145−1154.
- Gold J.A., Hoshino Y., Tanaka N., Rom W.N., Raju Π., Condos R., Weiden M.D. (2004) Surfactant protein A modulates the inflammatory response in macrophages during tuberculosis. Infect Immun. 72, 645−650.
- Gordon S., Clarke S., Greaves D. and Doyle A. (1995) Molecular immunobiology in macrophages: recent progress. Curr. Opin. Immunol. 7, 24−33.
- Govoni G., Vidal S., Gauthier S., Skamene E., Malo D. and Gros P. (1996) The Bcg/Ity/Lsh locus: genetic transfer of resistance to infection in C57BL/6J mice transgenic for the NramplGly'69 allele. Infect. Immun. 64, 2923−2929.
- Greenwood Π‘. M. Π’., Fujuwara M., Boothroyd L.J., Miller M.A., Frappier D., Fanning E.A., Schurr E. and Morgan K. (2000) Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large Canadian family. Am. J. Hum.Genet. 67, 405 416.
- Gros P. and Schurr E. (2002) Immunogenetics of the host response to bicteria in mice. Immunology of Infectious Diseases. AMS Press, Washington D.C. 407−419.
- Gros P., Scamene E., Forget A. (1981) Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. J. Immunol 127, 2417−2421.
- Gros P., Skamene E., Forget A. (1983) Cellular mechanisms of genetically controled host resistance to Mycobacterium bovis (BCG). J. Immunol. 127,2417−2421.
- Gruenheid S., Cannone-Hergaux F., Gauthier S., Hackman D.J., Grinstein S. and Gros P. (1999) The iron transport protein Nramp2 is an integral membrane protein that co-localizes with transferring in recycling endosomes. J. Exp. Med. 189, 831−841.
- Gruenheid S., Cellier M., Vidal S. and Gros P. (1995) Identification and characterization of a second mouse Nramp gene. Genomics 25, 514−525.
- Griineberg H. (1952) The resistance of infectious diseases. In The genetics of Mouse. The Hague: Martins Nijhoff, 421−434.
- Hannon G.J. RNA interference. Nature 418,244−251.
- Heinrich P.C., Behrmann I., Haan S., Hermanns H.M., Muller-Newen G., Schaper F. (2003) Principles if interleukin (IL)-6-type signaling and its regulation. Biochem. J. 374,1−20.
- Heller R.A., Schena M., Chai A., Shalon D., Bedilion Π’., Gilmore J., Woolley D.E., Davis R.W. (1997) Discovery and analysis of inflammatory disease-related genes using cDNA microarrays. PNAS 94,2150−2155.
- Henderson R.A., Watkins S.C., Flynn J.L. (1997) Activation of human dendritic cells following infection with Mycobacterium tuberculosis. J. Immunol. 159, 635−643.
- Hickman S.P., Chan J., Salgame P. (2002) Mycobacterium tuberculosis induces differential cytokine production from dendritic cells and macrophages with with divergent effects on naive T cell polarization. J. Immunol. 168,4636−4642.
- Hinman A.R., Judd J.M., Kolnick J. P and Daitch P.B. (1976) Changing risks in tuberculosis. Am. J. Epidemiol. 103,486−497.
- Hirsch C.S., Toossi Z., Vanham G., Johnson J.L., Peters P., Okwera A., Mugerwa R., Mugyenyi P., Ellner J.J. (1999) Apoptosis and T cell hyperresponsiveness in pulmonary tuberculosis. J. Infect. Dis.19, 945−953.
- Hirschhorn J.N., Sklar P., Lindblad-Toh K., Lim Y.M., Ruiz-Gutierrez M. et al. (2000) SBE-TAGS: an array-based method for efficient single-nucelotide polymorphism genotyping. PNAS USA 97, 12 164−12 169.
- Holt P. G., Degebrodt A., O’Leary C., et al. (1985) T cell activation by antigen-presenting cells from lung tissue digests: suppression by endogenous macrophages. Clin. Exp. Immunol. 62, 586−593.
- Huygen Π., Drowart A., Harboe M. et al. (1993) Influence of genes from the MHC on the antibody repertoire against culture filtrate antigens in mice infected with live Mycobacterium bovis BCG. Infect. Immun.61,2687−2693.
- Huygen K., Ljungovist L., ten Berg R., van Vooren J. (1990) Repertories of antibodies to culture filtrate antigens in different mouse strains infected with Mycobacterium bovis (BCG). Infect. Immunol.58, 2192−2197.
- Huygen K., Palfliet K., Jurion F., Hilgers J. (1988) H-2 linked control of in vitro interferon-y production in response to 32-kilodalton antigen (P32) of Mycobacterium bovis Bacillus Calmette- Guerin. Infect. Immun. 56, 3191−3200.
- Ivanyi J., Sharp K. (1986) Control by H-2 genes of murine antibody responses to protein antigens of Mycobacterium tuberculosis. Immunology 59, 329−332.
- Iyer VR, Eisen MB, Ross DT, Schuler G, Moore T, Lee JC, Trent JM, Staudt LM, Hudson J Jr, Boguski MS, Lashkari D, Shalon D, Botstein D, Brown PO. (1999) The transcriptional program in the response of human fibroblasts to serum. Science 283, 8387.
- Jansen R.C. (1993) Interval mapping of multiple quantitative loci. Genetics 135, 205 211.
- Jimenez-Sanchez G, Childs B, Valle D. (2001) Human disease genes. Nature 409, 853−855.
- Jing L., Cellier M., Schurr E., Skamene E. (1993) Comparative genome analysis -a novel strategy to study the genetics of host-parasite interactioa J.Parasitol. 79, 463 469.
- Jong R., Altare F., Haagen I.A., Elferink D.G., de Boer Π’., van Breda Vriesman P.G.C., Kabel P.J., Draaisma J.M.T., van Dissel J.T., Kroon F.P., Casanova J.L.,
- Ottenhoff Π’.Π.Π. (1998) Severe Mycobacterial and Salmonella infections in IL-12 receptor-deficient patients. Science 280,1435−1438.
- Jouanguy E., Altare F., Lamhamedi S., Revy P., Emile JF. Et al. (1996) Interferon-gamma-receptor deficiency in an infant with a fatal bacille Calmette-Guerin infection. N. Engl. J. Med. 335,1956−1961.
- Kallmann F.J. and Reisner D. (1942)Am. Rev. Tuberc. 47, 549−574.
- Kaufmann S.H.E., Flesh I. (1986) Function and antigen recognition pattern of L3T4+ T-cell clones from Mycobacterium tuberculosis immune mice. Infect. Immun. 54, 291 296.
- Kaufmann S.H.E. (2002) Protection against tuberculosis: cytokines, T cells, and macrophages. Ann. Rheum. Dis. 61, 54−58.
- Kramnik I. And Boyartchuk V. (2002) Immunity to intracellular pathogens as a complex genetic trait Curr. Op. Microb. 5,111−117.
- Kramnik I., Dietrich W., Demant P., and Bloom B.R. (2000) Genetic control of resistance to experimental infection with virulent Mycobacterium tuberculosis. PNAS USA 15, 8560−8565.
- Ladel C.H., Szalay G., Reidel D., Kaufmann S.H.E. (1997) Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages. Infect. Immun. 65, 1936−1938.
- Lam-Yuk-Tseung S. and Gros P. (2003) Genetic control of susceptibility to bacterial infections in mouse model. Cell. Microb. 5,299−313.
- Lander E.S. and Schork N.J. (1994) Genetic dissection of complex traits. Science. 265, 2037−2048.
- Laskin DL., Weinberger B. and Laskin JD. (2001) Functional heterogeneity in liver and lung macrophages. J. Leukocyte Biol. 70,163−170.
- Lavebratt C., Apt A.S., Nikonenko B.V., Schalling M., Schurr E. (1999) Severity of tuberculosis in mice linked to distal chromosome 3 and proximal chromosome 9. J. Infect. Dis. 180, 150−155.
- Lee W.L., Downey G.P. (2001) Neutrophil activation and acute lung injury. Curr. Opin. Crit. Care 7, 1−5.
- Lengeling A., Pfeffer K., Balling R. (2001) The battle of two genomes: genetics of bacterial host/pathogen interactions in mice. Mammalian Genome 12, 261−271.
- Lentsch A.B., Crouch L.D., Czermak B.J., Yun E.C., Guo R., Sarma V., Diehl Km., Ward P.A. (1999) Regulatory effects of interleukin-11 during acute lung inflammatory injury. J. Leukoc. Biol. 66,151−157.
- Lienhardt C. (2001) From exposure to disease: the role of environmental factors in susceptibility to and development of tuberculosis. Epidemiol. Rev. 23, 288−301
- Lindblad-Toh K., Winchester E., DalyM.J., Wang D.G., Hirschhorn J.N. et al. (2000) Large-scale discovery and genotyping of single-nucleotide polymorphisms in the mouse. Nat Genet 24, 381−386.
- Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, Chee MS, Mittmann M, Wang C, Kobayashi M, Horton H, Brown EL. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nature Biotechnol. 14, 1675−1880.
- Lowrie D.B., Tascon R.E., Bonato V.L.D., Lima V.M.F., Faccioli L.H., Stavropoulos E., Colston M.J., Hewinson R.G., Moelling K. and Silva C.L. (1999) Therapy of tuberculosis in mice be DNA vaccination. Nature 400,269−271.
- Lynch C. J., Pierce-Chase Π‘. H. and Dubos R. (1965) A genetic study of susceptibility to experimental tuberculosis in mice infected with mammalian tubercle bacilli. J. Exp. Med. 121, 1051−1070.
- MacMicking J.D., North R.J., LaCourse R., Mudgett J.S., Shah S.K., Nathan C.F. (1997) Identification of nitric oxide synthase as a protective locus against tuberculosis. PNAS USA 94, 5243−5248.
- Makui H., Roig E., Cole S.T., Helmann J.D., gros P. and Cellier M. (2000) Identification of Escherichia coli K-12 Nramp (mntH) as a selective divalent metal ion transporter. Mol. Microbiol 35,1065−1078.
- Malo D., Vidal S., Lieman J., Ward D. C, and Gros P. (1993b) Physical delineation of the minimal chromosomal segment encompassing the host resistance locus Beg. Genetics 17, 667−675.
- Malo D., Vidal S., Skamene E. and Gros P. (1993a) High resolution linkage map in the vicinity fo the host resistance locus Beg on mouse chromosome 1. Genomics 16, 655−663.
- Malo D., Vogan K., Vudal S., Hu J., Cellier M., Schurr E., Kuks A., Morgan K, and Gros P. (1994) Haplotype mapping and sequence analysis of the mouse Nramp gene predict susceptibility to infection with intracellular parasites. Genomics 23, 51−61.
- Marquet S., Lepage P., Hudson Π’., Musser J.M. and Schurr E. (2000) Complete nucleotide sequence and genomic structure of the human NRAMP1 gene region on human chromosome region 2q35. Mamm. Genome 11, 755−762.
- May M.E., Spagnuolo P.J. (1987) Evidence for activation of a respiratory burst in the interaction of human neutrophils with Mycobacterium tuberculosis. Inf. Immun. 55, 2304−2307.
- McCaffrey AP, Meuse L, Pham TT, Conklin DS, Hannon GJ, Kay MA. (2002) RNA interference in adult mice. Nature. 418, 38−9.
- Medina E. and North R.J. (1998) Resistance ranking of some common inbred mouse strains to Mycobacterium tuberculosis and relationship to major histocompatibility complex haplotype and Nrampl genotype. Immunology 93,270−274.
- Medina E., Rogerson B.J. and North R.J. (1996) The Nrampl antimicrobial resistance gene segregates independently of resistance to virulent Mycobacterium tuberculosis. Immunology 88,479−481.
- Mira MT, Alcais A, Van Thuc N, Thai VH, Huong NT, Ba NN, Verner A, Hudson TJ, Abel L, Schurr E. (2003) Chromosome 6q25 is linked to susceptibility to leprosy in a Vietnamese population. Nat Genet 33,412−5
- Mitsos L.-M., Cardon L.R., Fortin A., Ryan L., LaCrouse R., North R.J. and Gros P. (2000) Genetic control of susceptibility to infection with Mycobacterium tuberculosis in mice. Genes Immun. 1,467−477.
- Mitsos L.-M., Cardon L.R., Ryan L., LaCourse R., North R.J., and Gros P. (2003) Susceptibility to tuberculosis: a locus on mouse chromosome 19 (Trl-4) regulates Mycobacterium tuberculosis replication in the lungs. PNAS USA 11, 6610−6615.
- Morisette N., Gold E. and Aderem A. (1999) The macrophage a cell for all seasons. Trends Cell. Biol. 9, 199−201.
- Motulsky A. G. (1960) Hum. Biol. 32, 28−62.
- Nathan C. and Hibbs J. (1991) Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr. Opin. Immunol 3, 65−70.
- Nau G.J., Richmond J.F., Schlesinger A., Jennings E.G., Lander E.S., Young R.A. (2002) Human macrophage activation programs induced by bacterial pathogens. PNAS USA 99, 1503−1508.
- Newport M. J, Levin M. (1999) Genetic susceptibility to tuberculosis. J Infect.39, 117 121.
- Newport M.J., Huxley C.M., Huston S., Hawrylowicz C.M., Oostra B.A., Williamson R., Levin M. (1996) A mutation in interferon-gamma receptor gene and susceptibility to mycobacterial infections. N.Engl. J.Med. 335,1941−1949.
- Nikonenko B.V., Apt A.S., Moroz A. M, Averbakh M.M. (1985) Genetic analysis of susceptibility of mice to H37Rv tuberculosis infection: sensitivity versus relative resistance. Prog. Leukocyte Biol. 3, 291−299.
- Nikonenko B.V., Mezhlumova M.B., Apt A.S., Moroz A.M. (1989) Local adoptive transfer of delayed-type hypersensitivity to tuberculin from M. bovis BCG-infected mice. Folia Biol. 35, 255−258.
- Nikonenko B.V., Averbakh M.M., Lavebratt C., Schurr E., Apt A.S. (2000) Comparative analysis of mycobacterial infections in susceptible I/St and resistant A/Sn inbred mice. Tuber. Lung. Dis. 80, 15−25.
- Nikonenko B.V. and Hanrahan C. (2002) Murine model of tuberculosis. In vitro ans in vivo study. Rus. J. Immun. 7, 308−322.
- Nygardas P.T. and Hinkkanen A.E. (2002) Up-regulation of MMP8 and MMP9 activity in the BALB/C mouse spinal cord correlates with the severity of experimentalautoimmune encephalomyelitis. Clin. Exp. Immunol. 128, 245−254
- O’Brien L., Carmichael J., Lowrie D., Andrew P. (1994) Strains of Mycobacterium tuberculosis differ in susceptibility to reactive nitrogen intermediates in vitro. Infect. Immun. 62,5187−5190.
- Orme I.M., Collins F.M. (1983) Protection against Mycobacterium tuberculosis infection by adoptive immunotherapy. Requirement for T cell-deficient recipients. J. Exp. Med. 158,74−83.
- Orme I.M., Andersen P., Boom W.H. (1993) T cell response to Mycobacterium tuberculosis. J. Infect. Dis. 167,1481−1497.
- Parks W. C and Shapiro S.D. (2000) Matrix metalloproteinases in lung biology. Respir. Res. 2,10−19.
- Pasula R., Wright J.R., Kachel D.L., Martin W.J. 2nd. (1999) Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis. J Clin Invest. 103,483−90.
- Pichugin A.V., Khaidukov S.V., Moroz A.M., Apt A.S. (1998) Capacity of murine T cells to retain long-term responsiveness to mycobacterial antigens is controlled by the H-2 complex. Clin. Exp. Immunol. lll, 316−324.
- Plant J.E. and Glynn A.A. (1979) Locating Salmonella resistnace gen on mouse chromosome 1. Clin Exp Immunol 37, 1−6.
- Plant J.E., Blackwell J.M., O’Brien A.D., Bradley D.J., Glynn A.A. (1982) Are the Lsh and Ity disease resistance genes at one locus on mouse chromosome 1? Nature 297, 510−511.
- Poirie Π., Frey F., Hita M., Huguet E., Lemeunier F., Periquet G. and Carton Y. (2000) Drosophila resistance genes to parasitoids: chromosomal location and linkage analysis. Proc R Soc Lond Π Biol Sci. 267,1417−1421
- Pospelov L. E., Matrakshin A. G., Chernousova L. N. et al. (1996) Tubercle Lung Dis., 77, 77−88.
- Quiding-Jarbrink M., Smith D.A., Bancroft G.J. (2001) Production of matriz metalloproteinases in response to mycobacterial infection. Inf. Immun. 69, 5661−5670.
- Ragno S., Romano M., Howell S., Pappin D. J. C., Jenner P.J., Colston M.J. (2001) Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach. Immunol. 104, 99−108.
- Ricciardi-Castagnoli P. and Granucci F. (2002) Interpretation of the complexity of innate immune responses by functional genomics. Nature Rev. Immun. 2, 1−8,
- Rieder H.L., Kelly G.D., Bloch A.B., Cuthen G.M. and Snider D.E.(1991) Tuberculosis diagnosed at death in the United States. Chest. 100, 678−681.
- Rogner U. C and Avner P. Congenic mice: cutting tools for complex immune disorders. Nat. Rev. Immun. 3, 243−252.
- Rom W.N. and Garay S.M. (1996) Tuberculosis. Boston: Little Brown, p. 1002.
- Rosenberger CM, Scott MG, Gold MR, Hancock RE, Finlay BB. (2000) Salmonella typhimurium infection and lipolysaccharide stimulationinduce similar changes in macrophage gene expression. J. Immunol. 164, 5894−5904.
- Schena M., Shalon D. and Brown PO. (1995) Quantitative monitoring of gene-expression patterns with a complementary DNA microarray. Science 270,467−470.
- Schurr E., Skamene E., Forget A., Gros F. (1989) Linkage analysis of the Beg gene on mouse chromosom I. Identification of tightly linked marker. J. Immunology 12, 4507−4513.
- Schurr E., Buschman E., Malo D., Gros P., Skamene E. (1990) Immunogenetics of mycobacterial infections: mouse-human homologies. J. Infect. Dis 161, 634−639.
- Sebasiani G., Olien L., Gauthier S. Skamene E., Morgan K., Gros P. and Malo D. (1998) Mapping of genetic modulators of natural resistance to infection with Salmonella typhimurium in mice. Genomics 47, 180−186.
- Serbina N.V. and Flynn J.L. (1999) Early emergence of CD8+ T cells primed for production of type 1 cytokines in the lungs of Mycobacterium tuberculosis-infected mice. Infect. Immun. 67, 3980−3988.
- Shapiro S.D. (1999) The macrophage in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 160, S29-S32.
- Shapiro S.D. and Senior R.M. (1999) Martix metalloproteinases. Matrix degradation and more. Am. J. Respir. Cell Mol. Biol. 20, 1100−1102.
- Shilon M.U., MacMicking J.D., Nicholson S., Brause J.E., Potter S et al. (1999) Phenotype of mice and macrophages deficient in both phagocyte oxidase and inducible nitric oxide synthase. Immunity 10,29−38.
- Simonds B. (1963) Tuberculosis in twins (Pitman Medical Pub. Co., London), 1−81.
- Singh Π., Singh G., Trajkovic V., Sharma P. (2003) Intracellular expression of Mycobacterium tuberculosis-specific 10-kDa antigen down-regulates macrophage B7.1 expression and nitric oxide release. Clin Exp Immunol. 134, 70−7.
- Skamene E., Gros F., Forget A., Kongshavn P.A.L. (1982) Genetic regulation of resistance to intracellular pathogens. Nature 297, 506−509.
- Skamene E., Schurr E. and Gros P. (1998) Infection genomics: Nrampl as a major determinant of natural resistance to intracellular infections. Annu. Rev. Med. 49, 275 287.
- Stach J.L. Gros P., Forget A. and Skamene E. (1984) Phenotypic expression of genetically controlled natural resistance to Mycobacterium bovis (BCG). J. Immunol. 132, 888−892.
- Staskawicz Π.J., Mudgett m.B., Dangl J.L. and Galan J.E. (2001) Common and contrasting themes of plants and animal diseases. Science. 292,2285−2289.
- Staudt LM. and Brown PO. (2000) Genomic views of the immune system. Annu. Rev. Immunol. 18, 829−859.
- Stead W.W. (1992) Genetics and resistance to tuberculosis: could resistance be enhanced by genetic engineering? Ann Intern Med. 116,937−941.
- Stead W.W., Senner J.W., Reddick W.T. and Lofgren J.P. (1990) Racial differences in susceptibility to infection by Mycobacterium tuberculosis N. Engl. J. Med. 322, 422 427.
- Stevenson M., Kondratieva Π’., Apt A., Tam M., Skamene E. (1995) In vitro and in vivo T cell responses in mice using bronchopulmonary infection with mucoid Pseudomonas aureginosa. Clin. Exp. Immunol., 99, 98−102.
- Stokes R.W., Orme I., and Collins F.M. (1986) Role of mononuclear phagocytes in expression of resistance and susceptibility to Mycobacterium avium infections in mice. Infect. Immun. 54, 811−819.
- Supek F., Supekova L., Nelson N., Nelson H. (1996) A yeast manganese transporter related to the macrophage protein involved in conferring resistance to mycobacteria. PNAS USA 93,5105−5110
- Tusher V.G., Tibshirani R. and Chu R. (2000) Significance analysis of microarrays applied to the ionizing radiation response. PNAS 98,5116−5121.
- Vidal S., Belouchi A.M., Cellier M., Beatty B. and Gros P. (1995) Cloning and characterization of a second human NRAMP gene on chromosome 12ql3. Mamm. Genome 6,224−230.
- Vidal S., Pinner E., Gauthier S., Lepage P. and Gros P. (1996) Nrampl is an integral membrane phosphoglycoprotein absent from macrophages of inbred mouse strains susceptible to infection with intracellular parasites. J. Immunol. 157,3559−3568.
- Vidal S.M., Malo D., Vogan K., Skamene E., Gros P. (1993) Natural resistance to infection with intrcellular parasites: isolation of a candidate for Beg. Cell 73,469−485.
- Wang J., Wakeham J., Harkness R., Xing Z. (1999) Macrophages are a significant source of type 1 cytokines during mycobacterial infection. J. Clin. Invest. 103, 10 231 029.
- Wang Z., Homer R.J., Hong L., Cohn L., Lee C.G., Jung S., Elias J.A. (2000) IL-11 selectively inhibits aeroallergen-induced pulmonary eosinophilia and Th2 cytokine production. J. Immunol. 165, 2222−2231.
- Wang Z., Engler P., Longacre A. and Storb U. (2001) An efficient method for high-fidelity ΠΠΠ‘/Π ΠΠ‘ retrofitting with a selectable marker for mammalian-cell transfection. Genome Res. 11, 137−142.
- Wang ZM., Liu C. and Dzarski R. (2000) Chemokines as the main proinflammatory mediators in human monocytes activated by Staphylococcus aureus, peptidoglycan and endotoxin. J. Biol. Chem. 275,20 260−20 267.
- Wells Π‘. and Brown S.D. (2000) Genomics meets genetics: towardsa mutant map of the mouse. Mamm. Genome 11,472−477.
- WHO Report (2002) Global Tuberculosis Control. http://www.who.int/whr/2002/en/report.htm
- Wilson M.A., DeRisi J.L., Kirstensen K.K., Imboden P., Rane S., Brown P.O., Schoolnik G.K. (1999) Exploring drug-induced alterations in gene expression in Mycobacterium tuberculosis by microarray hybridization. PNAS 96,12 833−12 838.
- Wodicka L., Dong H., Mittmann M., ΠΠΎ M.H., Lockhart D.J. (1997) Genome-wide expression monitoring in Saccharomyces cerevisiae. Nature Biotechnol. 15, 1359−1367.
- Xue M.-L., Thakur A., Willcox M. (2002) Gene expression of pro-inflammatory cytokines and chemokines in mouse eye infected with Pseudomonas aeruginosa. Clin. Exp. Ophtalmology, 30, 196−199.
- Young D.B. and Duncan K. (1995) Prospects for new interventions in the treatment and prevention of mycobacterial disease. Annu. Rev. Microbiol. 49,47−55.
- Zheng Π’., Zhu Z., Wang J., Homer R.J., Elias J.S. (2001) IL-11: insights in asthma from overexpression transgenic modeling. J. Allergy Clin. Immunol. 108,489−496.
- Zinkernagel R.M., Doherty P.C. (1979) ΠΠΠ‘-restricted cytotoxic T cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness. Adv Immunol. 27, 51−177.